3.8.0.1 html 95 185 1 false 34 0 false 8 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biohavenpharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.biohavenpharma.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.biohavenpharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.biohavenpharma.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.biohavenpharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 10101 - Disclosure - Nature of the Business and Basis of Presentation Sheet http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of the Business and Basis of Presentation Notes 6 false false R7.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 10301 - Disclosure - Fair Value of Financial Assets and Liabilities Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilities Fair Value of Financial Assets and Liabilities Notes 8 false false R9.htm 10401 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 9 false false R10.htm 10501 - Disclosure - Equity Method Investment Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestment Equity Method Investment Notes 10 false false R11.htm 10601 - Disclosure - Accrued Expenses Sheet http://www.biohavenpharma.com/role/DisclosureAccruedExpenses Accrued Expenses Notes 11 false false R12.htm 10701 - Disclosure - Notes Payable Notes http://www.biohavenpharma.com/role/DisclosureNotesPayable Notes Payable Notes 12 false false R13.htm 10801 - Disclosure - Warrants Sheet http://www.biohavenpharma.com/role/DisclosureWarrants Warrants Notes 13 false false R14.htm 10901 - Disclosure - Convertible Preferred Shares Sheet http://www.biohavenpharma.com/role/DisclosureConvertiblePreferredShares Convertible Preferred Shares Notes 14 false false R15.htm 11001 - Disclosure - Common Shares Sheet http://www.biohavenpharma.com/role/DisclosureCommonShares Common Shares Notes 15 false false R16.htm 11101 - Disclosure - Net Loss per Share Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShare Net Loss per Share Notes 16 false false R17.htm 11201 - Disclosure - License and Other Agreements Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAndOtherAgreements License and Other Agreements Notes 17 false false R18.htm 11301 - Disclosure - Commitments and Contingencies Sheet http://www.biohavenpharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 11401 - Disclosure - Related Party Transactions Sheet http://www.biohavenpharma.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 19 false false R20.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 20 false false R21.htm 30303 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesTables Fair Value of Financial Assets and Liabilities (Tables) Tables http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilities 21 false false R22.htm 30403 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 22 false false R23.htm 30503 - Disclosure - Equity Method Investment (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestmentTables Equity Method Investment (Tables) Tables http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestment 23 false false R24.htm 30603 - Disclosure - Accrued Expenses (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.biohavenpharma.com/role/DisclosureAccruedExpenses 24 false false R25.htm 31103 - Disclosure - Net Loss per Share (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://www.biohavenpharma.com/role/DisclosureNetLossPerShare 25 false false R26.htm 40101 - Disclosure - Nature of the Business and Basis of Presentation - Initial Public Offering (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationInitialPublicOfferingDetails Nature of the Business and Basis of Presentation - Initial Public Offering (Details) Details 26 false false R27.htm 40102 - Disclosure - Nature of the Business and Basis of Presentation - Going Concern (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationGoingConcernDetails Nature of the Business and Basis of Presentation - Going Concern (Details) Details 27 false false R28.htm 40301 - Disclosure - Fair Value of Financial Assets and Liabilities (Details) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesDetails Fair Value of Financial Assets and Liabilities (Details) Details http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesTables 28 false false R29.htm 40302 - Disclosure - Fair Value of Financial Assets and Liabilities - Valuation of Contingent Equity Liability (Details) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesValuationOfContingentEquityLiabilityDetails Fair Value of Financial Assets and Liabilities - Valuation of Contingent Equity Liability (Details) Details 29 false false R30.htm 40303 - Disclosure - Fair Value of Financial Assets and Liabilities - Fair values of the company's liabilities (Details) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesFairValuesOfCompanySLiabilitiesDetails Fair Value of Financial Assets and Liabilities - Fair values of the company's liabilities (Details) Details 30 false false R31.htm 40401 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables 31 false false R32.htm 40501 - Disclosure - Equity Method Investment - Stock purchase agreement with Kleo (Details) Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestmentStockPurchaseAgreementWithKleoDetails Equity Method Investment - Stock purchase agreement with Kleo (Details) Details 32 false false R33.htm 40502 - Disclosure - Equity Method Investment - Carrying value and Summarized unaudited financial information for Kleo (Details) Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestmentCarryingValueAndSummarizedUnauditedFinancialInformationForKleoDetails Equity Method Investment - Carrying value and Summarized unaudited financial information for Kleo (Details) Details 33 false false R34.htm 40601 - Disclosure - Accrued Expenses (Details) Sheet http://www.biohavenpharma.com/role/DisclosureAccruedExpensesDetails Accrued Expenses (Details) Details http://www.biohavenpharma.com/role/DisclosureAccruedExpensesTables 34 false false R35.htm 40701 - Disclosure - Notes Payable - Credit Agreement (Details) Notes http://www.biohavenpharma.com/role/DisclosureNotesPayableCreditAgreementDetails Notes Payable - Credit Agreement (Details) Details 35 false false R36.htm 40801 - Disclosure - Warrants - Guarantor and Co-Guarantor Warrants (Details) Sheet http://www.biohavenpharma.com/role/DisclosureWarrantsGuarantorAndCoGuarantorWarrantsDetails Warrants - Guarantor and Co-Guarantor Warrants (Details) Details 36 false false R37.htm 40901 - Disclosure - Convertible Preferred Shares (Details) Sheet http://www.biohavenpharma.com/role/DisclosureConvertiblePreferredSharesDetails Convertible Preferred Shares (Details) Details http://www.biohavenpharma.com/role/DisclosureConvertiblePreferredShares 37 false false R38.htm 41001 - Disclosure - Common Shares - IPO & Private Placement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureCommonSharesIpoPrivatePlacementDetails Common Shares - IPO & Private Placement (Details) Details 38 false false R39.htm 41101 - Disclosure - Net Loss per Share (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShareDetails Net Loss per Share (Details) Details http://www.biohavenpharma.com/role/DisclosureNetLossPerShareTables 39 false false R40.htm 41102 - Disclosure - Net Loss per Share - Antidilutive Securities Excluded from EPS (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShareAntidilutiveSecuritiesExcludedFromEpsDetails Net Loss per Share - Antidilutive Securities Excluded from EPS (Details) Details 40 false false R41.htm 41201 - Disclosure - License and Other Agreements (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAndOtherAgreementsDetails License and Other Agreements (Details) Details http://www.biohavenpharma.com/role/DisclosureLicenseAndOtherAgreements 41 false false R42.htm 41301 - Disclosure - Commitments and Contingencies - Lease Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureCommitmentsAndContingenciesLeaseAgreementDetails Commitments and Contingencies - Lease Agreement (Details) Details 42 false false R43.htm 41401 - Disclosure - Related Party Transactions (Details) Sheet http://www.biohavenpharma.com/role/DisclosureRelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.biohavenpharma.com/role/DisclosureRelatedPartyTransactions 43 false false All Reports Book All Reports bhvn-20180331.xml bhvn-20180331.xsd bhvn-20180331_cal.xml bhvn-20180331_def.xml bhvn-20180331_lab.xml bhvn-20180331_pre.xml http://fasb.org/us-gaap/2016-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true